STOCK TITAN

If You Invested in ONCOLOGY PHARMA INC (ONPH)

Financial Services · Shell Companies · OTC
Looking for the current price? See the ONPH quote & overview
$1,000 invested 1 Year Ago
$180,000
+17,900.0% price return 18,223.9% CAGR
+17,900.0% with dividends reinvested
Bought on Oct 30, 2025 at $0.0002 split-adjusted
$1,000 invested 5 Years Ago
$3
-99.7% price return -68.2% CAGR
-99.7% with dividends reinvested
Bought on Nov 1, 2021 at $10.88 split-adjusted

What $1,000 or $10,000 in ONPH Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Nov 2, 2015
$1,000 $180,000 +17,900% $3 -100% $5 -100% $0 -100%
$10,000 $1,800,000 +17,900% $33 -100% $48 -100% $0 -100%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-10-29. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for ONPH

$1,000 Investment Over Time

ONPH vs S&P 500

Year-by-Year Returns

ONPH annual performance
Year Start Price End Price Annual Return Cumulative
2015 $1980.00 $100.00 -94.9% -94.9%
2016 $100.00 $1.11 -98.9% -99.9%
2017 $1.11 $1.25 +12.6% -99.9%
2018 $1.25 $1.03 -17.6% -99.9%
2019 $1.03 $1.90 +84.5% -99.9%
2020 $1.90 $0.4320 -77.3% -100.0%
2021 $0.4320 $4.05 +837.5% -99.8%
2022 $4.05 $0.3386 -91.6% -100.0%
2023 $0.3386 $0.0002 -99.9% -100.0%
2024 $0.0002 $0.0001 -50.0% -100.0%
2025 $0.0001 $0.0040 +3900.0% -100.0%
2026 $0.0040 $0.0360 +800.0% -100.0%

About ONCOLOGY PHARMA INC

Financial Services · OTC

Market Cap
$0.0B
Current Price
$0.0360
View full ONPH overview

Frequently Asked Questions

ONCOLOGY PHARMA INC investment returns

How much would $1,000 invested in ONCOLOGY PHARMA INC be worth today?

If you invested $1,000 in ONCOLOGY PHARMA INC (ONPH) 10 years ago on 2016-10-31, your investment would be worth $5 as of 2026-10-29, a -99.5% price return without dividends, growing at a compounded rate of -41.4% per year (CAGR).

Has ONCOLOGY PHARMA INC outperformed the S&P 500?

Over the past 10 years, ONPH returned -99.5% compared to +262.1% for the S&P 500, underperforming the benchmark by 361.6 percentage points.

What is ONCOLOGY PHARMA INC's average annual return?

The compound annual growth rate (CAGR) of ONPH’s share price over the past 10 years is -41.4%, without dividends. Individual years vary a great deal, and ONPH’s best recent full year was 2025 (+3900.0%) while the worst was 2023 (-99.9%).

For informational and educational purposes only, not investment advice.